Mestag Therapeutics Alternatives & Competitors

12 companies similar to Mestag Therapeutics — New therapies for inflammatory disease and cancer by targeting fibroblast immuno...

CV6 Therapeutics, (NI) Ltd.

CV6 Therapeutics is dedicated to improving patients lives through the development of novel...

11 Series Unknown $8.00M

United Kingdom

Biotechnology Health Care +1

Repertoire Immune Medicines

Repertoire is a biotechnology company creating a new category of immune medicines for canc...

86 Series B $189.00M

Cambridge, United States

Biotechnology Health and Wellness +1

Replicate Bioscience, Inc.

The Power of RNA Amplified

22 Series A $46.00M

San Diego, United States

Biotechnology

Sitryx

Harnessing the power of cell metabolism to develop groundbreaking disease-modifying therap...

48 Series A $79.00M

Oxford, United Kingdom

Biotechnology Health Care +1

Track all Mestag Therapeutics competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Mersana Therapeutics

Our mission is to discover and develop life-changing antibody-drug conjugates (ADCs) for p...

159 Acquired $534.80M

Cambridge, United States

Biotechnology Health Care +1

Vial

Vial is a next-gen pharma company advancing best-in-class biologics and RNA therapeutics a...

156 Series B $67.00M

San Francisco, United Sta...

Biotechnology Pharmaceutical

STORM Therapeutics Limited

Harnessing the power of RNA modification

16 Series C $116.50M

Cambridge, United Kingdom

Biotechnology Health Care +1

Granza Bio

Reprogramming Immunity for Target-Specific Medicines

7 Seed $7.64M

Biopharma Biotechnology +1

REGENXBIO

Seeking to improve lives through the curative potential of gene therapy.

389 IPO $1.58B

Rockville, United States

Biopharma Biotechnology +1

Takeda

Better Health, Brighter Future

37130 IPO $57.80M

Tokyo, Japan

Biotechnology Pharmaceutical

Evommune

Developing innovative therapies that target key drivers of chronic inflammatory diseases.

69 Unknown $493.00M

Palo Alto, United States

Biotechnology Health Care +1

Tridek-One

We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseas...

12 Series Unknown $19.00M

Paris, France

Biotechnology Health Care +1

About Mestag Therapeutics

New therapies for inflammatory disease and cancer by targeting fibroblast immunology

Services

Development of first-in-class antibodies, Therapeutics targeting fibroblast immunology, Advanced research in cancer and inflammatory diseases, Agonist antibodies for immune response regulation

Target Customers

Patients with cancer, Patients with inflammatory diseases such as RA, IBD, and lupus, Healthcare providers, Research organizations in immunology

Taxonomy

Fibroblast Technology, Immunology, Oncology, Inflammatory Disease, Antibody Programs, Immune Interactions, Cancer Treatment, Immuno-oncology, Therapeutics, Drug Development, Innovative Treatments, Fibroblast-immune Interactions, First-in-class Therapies, Biopharmaceuticals

Business Model

B2B, B2D

Revenue Model

Licensing, Performance Based

Frequently Asked Questions

Top alternatives to Mestag Therapeutics include CV6 Therapeutics, (NI) Ltd., Repertoire Immune Medicines, Replicate Bioscience, Inc., Sitryx, Mersana Therapeutics. These companies serve similar markets and are frequently compared.

Bounce Watch tracks 12 companies similar to Mestag Therapeutics based on industry overlap, target customers, and business model.

New therapies for inflammatory disease and cancer by targeting fibroblast immunology

Don't just read about them. Follow them.

BounceWatch watches Mestag Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Mestag Therapeutics Profile CV6 Therapeutics, (NI) Ltd. Alternatives Repertoire Immune Medicines Alternatives Replicate Bioscience, Inc. Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Mestag Therapeutics on 18 Mar 2026. The 12 companies listed here were last checked between 24 Feb 2025 and 2 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.